The HCFO program ended in December 2016.
This site will no longer be updated, and some elements may not appear correctly.
- in Policy Brief by Arnold, S.A. and B.J. Austin
- in Grantee Publication by Taylor, D.H.
The effect of hospice on third-party payer costs has long been of great interest in the United States and other nations. The choice of hospice could also influence the costs experienced by patients and family members as compared with when Medicare beneficiaries choose to use normal care. This article considers both types of cost in the context of the United States.
- in Grantee Publication by Ralston, J.D., Martin, D.P., Anderson, M.L., Fishman, P.A., Conrad, D.A., Larson, E.B., and D. Grembowski
- in Grantee Publication by Center for Advancing Health
- Hospital Ownership and Medical Services: Market Mix; Spillover Effects; and Nonprofit Objectives June 18, 2009in Grantee Publication by Horwitz, J.R. and A. Nichols
- in Grantee Publication by Frakt, A.B., Pizer, S.D., and R. Feldman
- in Grantee Publication by Bishop, C.E., Ryan, A.M., Gilden, D.M., Kubisiak, J., and Thomas, C.P.
To estimate the impact of a soft cap (a ceiling on utilization beyond which insured enrollees pay a higher copayment) on low-income elders’ use of prescription drugs.